Transplant Digest newsletter - Spring/Summer 2021 (issue 30)

Page 1

Transplant Digest SPRING/SUMMER 2021 ISSUE NO. 30

COVID-19 Vaccines and the Canadian Landscape Dr. Jeff Zaltzman

At the time of writing, approximately 50% of Canadians received at least one dose of a Health Canada-approved vaccine, and 3% received a second dose. Product monographs for the two mRNA vaccines, Pfizer-BioNTech, and Moderna, recommend a second dose at 21 and 28 days respectively. The recommended second dose for the virus vector vaccine by Astra Zeneca is between 10-12 weeks following the first. The other approved virus vector vaccine by Johnson and Johnson requires only a single dose. What have we done in Canada with respect to vaccine rollouts? Owing to world-wide demand and supply limitations, Canada had a slow and tumultuous vaccine procurement early on. None of the COVID-19 vaccines are manufactured in Canada, Continued on page 2

In this issue... • COVID-19 Vaccines and the Canadian Landscape • Understanding if COVID-19 Vaccines are Effective • Preparing for your Virtual Clinic Visit • Your Lab Requisition • Having a baby after a kidney transplant • How much water should you drink each day? • Iron Deficiency after Transplant • My CPAP Journey • Post Transplant Chat : Knowing your medication • Adjusting Transplant Research Participation to Pandemic Limitations • Writing to your donor family TRANSPLANT DIGEST - PG 1


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.